| Replication of CLU, CR1, and PICALM associations with alzheimer disease MM Carrasquillo, O Belbin, TA Hunter, L Ma, GD Bisceglio, F Zou, ... Archives of neurology 67 (8), 961-964, 2010 | 268 | 2010 |
| Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study J Fortea, E Vilaplana, M Carmona-Iragui, B Benejam, L Videla, I Barroeta, ... The Lancet 395 (10242), 1988-1997, 2020 | 219 | 2020 |
| Confluence of α-synuclein, tau, and β-amyloid pathologies in dementia with Lewy bodies M Colom-Cadena, E Gelpi, S Charif, O Belbin, R Blesa, MJ Martí, ... Journal of Neuropathology & Experimental Neurology 72 (12), 1203-1212, 2013 | 181 | 2013 |
| Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study J Fortea, M Carmona-Iragui, B Benejam, S Fernández, L Videla, ... The Lancet Neurology 17 (10), 860-869, 2018 | 167 | 2018 |
| SERPINA3 (aka alpha-1-antichymotrypsin) C Baker, O Belbin, N Kalsheker, K Morgan Front Biosci 12 (8-12), 2821-2835, 2007 | 158 | 2007 |
| Changes in synaptic proteins precede neurodegeneration markers in preclinical Alzheimer's disease cerebrospinal fluid A Lleó, R Núñez-Llaves, D Alcolea, C Chiva, D Balateu-Paños, ... Molecular & Cellular Proteomics 18 (3), 546-560, 2019 | 150 | 2019 |
| YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer’s disease and other tauopathies M Querol-Vilaseca, M Colom-Cadena, J Pegueroles, ... Journal of neuroinflammation 14, 1-10, 2017 | 126 | 2017 |
| Synaptic phosphorylated α-synuclein in dementia with Lewy bodies M Colom-Cadena, J Pegueroles, AG Herrmann, CM Henstridge, L Munoz, ... Brain 140 (12), 3204-3214, 2017 | 100 | 2017 |
| Replication of BIN1 association with Alzheimer's disease and evaluation of genetic interactions MM Carrasquillo, O Belbin, TA Hunter, L Ma, GD Bisceglio, F Zou, ... Journal of Alzheimer's Disease 24 (4), 751-758, 2011 | 84 | 2011 |
| Replication of EPHA1 and CD33 associations with late-onset Alzheimer's disease: a multi-centre case-control study MM Carrasquillo, O Belbin, TA Hunter, L Ma, GD Bisceglio, F Zou, ... Molecular neurodegeneration 6, 1-9, 2011 | 83 | 2011 |
| The dopamine β-hydroxylase-1021C/T polymorphism is associated with the risk of Alzheimer's disease in the Epistasis Project O Combarros, DR Warden, N Hammond, M Cortina-Borja, O Belbin, ... BMC medical genetics 11, 1-10, 2010 | 72 | 2010 |
| Differential levels of Neurofilament Light protein in cerebrospinal fluid in patients with a wide range of neurodegenerative disorders C Delaby, D Alcolea, M Carmona-Iragui, I Illán-Gala, ... Scientific reports 10 (1), 9161, 2020 | 71 | 2020 |
| Investigation of 15 of the top candidate genes for late-onset Alzheimer’s disease O Belbin, MM Carrasquillo, M Crump, OJ Culley, TA Hunter, L Ma, ... Human genetics 129, 273-282, 2011 | 69 | 2011 |
| Concordant association of insulin degrading enzyme gene (IDE) variants with IDE mRNA, Aß, and Alzheimer's disease MM Carrasquillo, O Belbin, F Zou, M Allen, N Ertekin-Taner, M Ansari, ... PloS one 5 (1), e8764, 2010 | 69 | 2010 |
| Transferrin and HFE genes interact in Alzheimer's disease risk: the Epistasis Project DJ Lehmann, M Schuur, DR Warden, N Hammond, O Belbin, H Kölsch, ... Neurobiology of aging 33 (1), 202. e1-202. e13, 2012 | 67 | 2012 |
| Replication by the Epistasis Project of the interaction between the genes for IL-6 and IL-10 in the risk of Alzheimer's disease O Combarros, CM van Duijn, N Hammond, O Belbin, A Arias-Vásquez, ... Journal of neuroinflammation 6, 1-9, 2009 | 67 | 2009 |
| Association of Alzheimer disease with life expectancy in people with Down syndrome MF Iulita, DG Chavez, MK Christensen, NV Tamayo, O Plana-Ripoll, ... JAMA network open 5 (5), e2212910-e2212910, 2022 | 63 | 2022 |
| Nanoscale structure of amyloid-β plaques in Alzheimer’s disease M Querol-Vilaseca, M Colom-Cadena, J Pegueroles, R Nuñez-Llaves, ... Scientific reports 9 (1), 5181, 2019 | 63 | 2019 |
| Weight loss in the healthy elderly might be a non-cognitive sign of preclinical Alzheimer's disease A Jimenez, J Pegueroles, M Carmona-Iragui, E Vilaplana, V Montal, ... Oncotarget 8 (62), 104706, 2017 | 63 | 2017 |
| The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: a data set for biomarker discovery and validation in neurodegenerative disorders D Alcolea, J Clarimón, M Carmona-Iragui, I Illán-Gala, ... Alzheimer's & Dementia: Translational Research & Clinical Interventions 5 …, 2019 | 62 | 2019 |
